Protein expression of RPL23A was also validated to be upregulated in CRC samples through western blotting by randomly selecting 6 paired tumor and normal samples (Figure 2C) and also further verified according to the results of IHC based on 50 CRC tumor-adjacent normal samples and corresponding matched tumor samples (Figure 2D). The gene discussed is RPL23A; the disease is colorectal carcinoma.